News Home

Analyst Rating: Will Quoin Pharmaceuticals Ltd - ADR (QNRX) Stock Do Better Than the Market?

Thursday, January 13, 2022 11:05 AM | InvestorsObserver Analysts

Mentioned in this article

Analyst Rating: Will Quoin Pharmaceuticals Ltd - ADR (QNRX) Stock Do Better Than the Market?

InvestorsObserver is giving Quoin Pharmaceuticals Ltd - ADR (QNRX) an Analyst Rating Rank of 74, meaning QNRX is ranked higher by analysts than 74% of stocks. The average price target for QNRX is $8 and analyst’s rate the stock as a Strong Buy.

Overall Score - 5
Wall Street analysts are rating QNRX a Strong Buy today. Find out what this means to you and get the rest of the rankings on QNRX!

Why are Analyst Ratings Important?

Fundamental research of the underlying health of a company can be an extremely useful resource when making investment decisions. Analysts observe growth prospects and forecasted earnings of companies to gain a comprehensive view of particular industries. This data allows traders to react before numbers are officially reported. InvestorsObserver takes the ratings from these analysts and percentile ranks those aveages. This allows you to compare stocks extensively and in more detail than the common buy/hold/sell ratings.

What's Happening With Quoin Pharmaceuticals Ltd - ADR Stock Today?

Quoin Pharmaceuticals Ltd - ADR (QNRX) stock is trading at $1.72 as of 11:04 AM on Thursday, Jan 13, a drop of -$0.13, or -7.03% from the previous closing price of $1.85. The stock has traded between $1.68 and $1.84 so far today. Volume today is below average. So far 337,194 shares have traded compared to average volume of 3,980,199 shares. Click Here to get the full Stock Report for Quoin Pharmaceuticals Ltd - ADR stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App